Innovating Works

Terumo BCT

Desconocido
NEPHSTROM: Novel Stromal Cell Therapy for Diabetic Kidney Disease TERUMO BCT EUROPE NV participó en un H2020: H2020-PHC-2014-2015 Type 2 diabetes will affect >500 million adults by 2040 and its secondary complications will generate enormous socioeconomic costs - in part...
2015-04-08 - 2021-10-31 | Financiado
SCIENCE: Stem Cell therapy in IschEmic Non treatable Cardiac diseasE SCIENCE TERUMO BCT EUROPE NV participó en un H2020: H2020-PHC-2014-2015 Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) With more than 17 million deaths worldwide each year, ischemic heart...
2014-12-03 - 2020-12-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... TERUMO BCT EUROPE NV participó en un FP6: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... TERUMO BCT EUROPE NV participó en un FP7: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.